Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 5 (2008), Issue 10 (October)

1. Green tea consumption and lung cancer risk: the Ohsaki study.
   Br J Cancer, 99(7): 1179-84. [Abstract] [Full-text]
2. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
   Cancer Chemother Pharmacol, 63(1): 167-74. [Abstract] [Full-text]
3. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.
   Cancer Chemother Pharmacol, 63(1): 117-26. [Abstract] [Full-text]
4. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
   Cancer Chemother Pharmacol, 63(1): 19-26. [Abstract] [Full-text]
5. Does saturable formation of gemcitabine triphosphate occur in patients?
   Cancer Chemother Pharmacol, 63(1): 55-64. [Abstract] [Full-text]
6. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.
   Cancer Chemother Pharmacol, 63(1): 175-9. [Abstract] [Full-text]
7. In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.
   Cancer Chemother Pharmacol, 63(1): 45-53. [Abstract] [Full-text]
8. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.
   Carcinogenesis, 29(10): 1938-43. [Abstract] [Full-text]
9. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma.
   Carcinogenesis, 29(10): 1979-85. [Abstract] [Full-text]
10. First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.
    Am J Respir Crit Care Med, 178(8): 847-53. [Abstract] [Full-text]
11. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    J Nucl Med, 49(10): 1606-12. [Abstract] [Full-text]
12. Modelling Myc inhibition as a cancer therapy.
    Nature, 455(7213): 679-83. [Abstract] [Full-text]
13. Leaving home early: reexamination of the canonical models of tumor progression.
    Cancer Cell, 14(4): 283-4. [Abstract] [Full-text]
14. Original triazine inductor of new specific molecular targets, with antitumor activity against nonsmall cell lung cancer.
    Int J Cancer, 123(11): 2676-83. [Abstract] [Full-text]
15. EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance.
    Int J Cancer, 123(11): 2480-6. [Abstract] [Full-text]
16. Preneoplastic and neoplastic lesions in the lung, liver and urinary tract of mice exposed to environmental cigarette smoke and UV light since birth.
    Int J Cancer, 123(11): 2497-502. [Abstract] [Full-text]
17. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
    Int J Cancer, 123(11): 2616-25. [Abstract] [Full-text]
18. The prognostic value of 18F-fluorodeoxyglucose uptake by using serial positron emission tomography and computed tomography in patients with stage III nonsmall cell lung cancer.
    Am J Clin Oncol, 31(5): 470-5. [Abstract] [Full-text]
19. Simultaneous cytological diagnosis of herpes simplex virus infection and primary lung cancer: report of two cases.
    Diagn Cytopathol, 36(11): 818-22. [Abstract] [Full-text]
20. A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors.
    Hum Genet, 124(3): 279-85. [Abstract] [Full-text]
21. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
    Cancer, 113(8): 2129-38. [Abstract] [Full-text]
22. Sclerosing hemangioma, presenting as a pneumonic pattern with mucinous adenomatous hyperplasia of the lung.
    Pathol Int, 58(11): 735-40. [Abstract] [Full-text]
23. Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma.
    Pathol Int, 58(11): 730-4. [Abstract] [Full-text]
24. Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
    Pathol Int, 58(11): 706-12. [Abstract] [Full-text]
25. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.
    Jpn J Clin Oncol, 38(10): 661-9. [Abstract] [Full-text]
26. Patient-perceived barriers to the psychological care of Japanese patients with lung cancer.
    Jpn J Clin Oncol, 38(10): 653-60. [Abstract] [Full-text]
27. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial.
    Surgery, 144(4): 712-7; discussion 717-8. [Abstract] [Full-text]
28. Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice.
    Cancer Lett, 271(2): 333-41. [Abstract] [Full-text]
29. Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
    Mol Cancer Ther, 7(10): 3408-19. [Abstract] [Full-text]
30. PET/CT for staging and monitoring non small cell lung cancer.
    Cancer Imaging, 8: S27-31. [Abstract] [Full-text]
31. CT screening for lung cancer.
    Cancer Imaging, 8: S24-6. [Abstract] [Full-text]
32. Tumour ablation: current role in the liver, kidney, lung and bone.
    Cancer Imaging, 8: S1-5. [Abstract] [Full-text]
33. Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE).
    J Pathol, 216(3): 365-74. [Abstract] [Full-text]
34. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung.
    Cancer Res, 68(20): 8582-9. [Abstract] [Full-text]
35. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
    Cancer Res, 68(20): 8547-54. [Abstract] [Full-text]
36. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
    Cancer Res, 68(20): 8535-40. [Abstract] [Full-text]
37. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.
    Cancer Res, 68(20): 8377-83. [Abstract] [Full-text]
38. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.
    Cancer Res, 68(20): 8295-303. [Abstract] [Full-text]
39. NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells.
    Biochem Biophys Res Commun, 376(2): 283-7. [Abstract] [Full-text]
40. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Acta Radiol, 49(9): 995-1004. [Abstract] [Full-text]
41. Computed tomography-guided core-needle biopsy specimens demonstrate epidermal growth factor receptor mutations in patients with non-small-cell lung cancer.
    Acta Radiol, 49(9): 991-4. [Abstract] [Full-text]
42. Bilateral massive renal angiomyolipoma concurrent with oncocytoma in tuberous sclerosis complex associated with pulmonary lymphangioleiomyomatosis.
    Urology, 72(4): 948.e7-9. [Abstract] [Full-text]
43. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.
    J Clin Oncol, 26(30): 4906-11. [Abstract] [Full-text]
44. Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis.
    Cancer Lett, 271(1): 105-16. [Abstract] [Full-text]
45. Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience.
    Radiology, 249(2): 671-81. [Abstract] [Full-text]
46. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.
    Gene Ther, 15(21): 1446-53. [Abstract] [Full-text]
47. Lung cancer and vehicle exhaust in trucking industry workers.
    Environ Health Perspect, 116(10): 1327-32. [Abstract] [Full-text]
48. SCLC extensive disease--treatment guidance by extent or/and biology of response?
    Radiat Oncol, 3: 33. [Abstract] [Full-text]
49. Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals.
    Clin Immunol, 129(2): 230-40. [Abstract] [Full-text]
50. Performance evaluation of a computer-aided detection algorithm for solid pulmonary nodules in low-dose and standard-dose MDCT chest examinations and its influence on radiologists.
    Br J Radiol, 81(971): 841-7. [Abstract] [Full-text]
51. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan.
    Am J Respir Crit Care Med, 178(9): 956-61. [Abstract] [Full-text]
52. Somatic mutations affect key pathways in lung adenocarcinoma.
    Nature, 455(7216): 1069-75. [Abstract] [Full-text]
53. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer.
    Am J Pathol, 173(5): 1551-65. [Abstract] [Full-text]
54. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
    BMC Cancer, 8: 284. [Abstract] [Full-text]
55. Intakes of fruit, vegetables, and specific botanical groups in relation to lung cancer risk in the NIH-AARP Diet and Health Study.
    Am J Epidemiol, 168(9): 1024-34. [Abstract] [Full-text]
56. Comparison of statistical methods for estimating genetic admixture in a lung cancer study of African Americans and Latinos.
    Am J Epidemiol, 168(9): 1035-46. [Abstract] [Full-text]
57. Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
    Ann Oncol, 19(11): 1903-9. [Abstract] [Full-text]
58. HER-2 protein overexpression in metastatic breast carcinoma found at autopsy.
    Jpn J Clin Oncol, 38(11): 743-7. [Abstract] [Full-text]
59. Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
    Cancer, 113(9): 2512-7. [Abstract] [Full-text]
60. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Cancer, 113(9): 2524-31. [Abstract] [Full-text]
61. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
    Cancer, 113(9): 2518-23. [Abstract] [Full-text]
62. Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.
    Am J Surg Pathol, 32(11): 1699-708. [Abstract] [Full-text]
63. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.
    Am J Surg Pathol, 32(11): 1727-35. [Abstract] [Full-text]
64. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
    Am J Surg Pathol, 32(11): 1627-42. [Abstract] [Full-text]
65. Reproducibility of interfraction lung motion probability distribution function using dynamic MRI: statistical analysis.
    Int J Radiat Oncol Biol Phys, 72(4): 1228-35. [Abstract] [Full-text]
66. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 72(4): 967-71. [Abstract] [Full-text]
67. Management of patients with concomitant lung cancer and abdominal aortic aneurysm.
    Am J Surg, 196(5): 697-702. [Abstract] [Full-text]
68. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study.
    Lancet, 372(9648): 1473-83. [Abstract] [Full-text]
69. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.
    Br J Cancer, 99(9): 1476-83. [Abstract] [Full-text]
70. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
    J Clin Oncol, 26(31): 5052-9. [Abstract] [Full-text]
71. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    J Clin Oncol, 26(31): 5043-51. [Abstract] [Full-text]
72. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.
    J Clin Oncol, 26(31): 5060-6. [Abstract] [Full-text]
73. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid.
    J Clin Oncol, 26(31): 5067-73. [Abstract] [Full-text]

© 2004-2010 Lung Cancer Research Today. All Rights Reserved.